ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML
USPTO (United States) · Serial 87703113
- Status
- registered
- Status updated
- 22 September 2020
- Filing date
- 30 November 2017
- Registration date
- 22 September 2020
- Nice classification
- 5
- Owner
- FIDELIS PHARMACEUTICALS LLC
- Owner country
- US
- Raw status code
- 700
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 87703113) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.